Our group of world-leading clinical, genetic and basic science researchers focus their work on understanding the causes and biological mechanisms leading to Neuromuscular Disease and translating this knowledge into developing novel therapeutic solutions.
The Department hosts a number of important Research Centres, including the MRC International Centre for Genomic Medicine in Neuromuscular Diseases, the UCL Queen Square Motor Neuron Disease Centre as well as the Alzheimer’s Research UK Drug Discovery Institute (ARUK-DDI). The Department also supports delivery and development of clinical services for patients with neuromuscular diseases.
Head of Department
Research Centres

Rare Disease Day
For Rare Disease Day 2025, the Neurogenetics Lab at UCL Queen Square Institute of Neurology celebrated the invaluable contributions of our international collaborators.

Departmental Equality Diversity Inclusion
Our committee of staff and students is here to provide support and information to all colleagues as staff and student members of the department
Training and Education
The Department and affiliated Research Centres offer excellent facilities for Postgraduate Training. There are currently 66 Postgraduate students in the Department who participate in regular series of student research talks, journal clubs as well as the UCL Queen Square Motor Neuron Disease Centre Seminar Series. Many of our Postgraduate students have gone on to pursue exciting international careers in neuroscience. Our academic staff are able to devote a significant proportion of their time to supervision and training of research students, and are available to support and guide you in undertaking your research, developing research skills and techniques, and in preparation of your written thesis. The Department also offers support to Postgraduate students by means of its Graduate Tutor and with a regular appraisal and reporting system. A particular attraction to our students is the facility to choose optional topics from the Institute of Neurology's MSc courses, seminars and workshops. The Department plays a leading role in the delivery of the MSc and Short Courses in Neuromuscular Disease.
For more information on PhD, MSc and MRes opportunities, visit Queen Square Institute of Neurology - Study at Queen Square Institute of Neurology
Departmental Lead for Bullying and Harassment: Professor Elizabeth Fisher
UCL is committed to investigating and stopping any incidences of bullying and harassment including sexual misconduct. A well-defined set of procedures for staff and students are in place for reporting and support. These procedures may be informal or formal depending on the situation. Please visit report-support.ucl.ac.uk (https://report-support.ucl.ac.uk/) for more information.
Professor Elizabeth Fisher has been appointed as the Department of Neuromuscular Diseases Lead for bullying and harassment. Professor Fisher has an open-door policy for members of the Department for advice on any issues or concerns relating to bullying, harassment or sexual misconduct. All discussions will of course be kept in compete confidence.
Professor Fisher can be contacted at elizabeth.fisher@ucl.ac.uk and her office is within Room 405 in Queen Square House.
In addition, the Head of Department can be contacted at any time if you have any issues or concerns you want to discuss.
Contact
Departmental Administrator: Kully Sunner - 020 3108 2725; k.sunner@ucl.ac.uk
General Admin: Debbie Hadley, Irina Proulova - sobell.admin@ucl.ac.uk

Head of Department
News

Professor Schiavo elected to Academia Europaea
We're delighted to announce the election of Professor Schiavo (Professor of Cellular Neuroscience, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology) to Academia Europaea.
09 Jun 2025

New insights into the treatment of ALS: MIROCALS clinical trial results published in The Lancet
Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published today in The Lancet.
12 May 2025

Charcot-Marie-Tooth Association Invests $210K in Long-Read Sequencing to Accelerate Gene Discovery
The Charcot-Marie-Tooth Association (CMTA) has announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease
23 Apr 2025
What's on
View all events26 Jun
in person
Queen Square Inaugural Lectures: Professor Rob Pitceathly and Professor Rimona Weil17:00 - 19:00

05 Sep
hybrid
UCL Queen Square Motor Neuron Disease Centre Sixth ALS/MND International Symposium09:30 - 17:30
